Literature DB >> 33772057

Associations of pathological diagnosis and genetic abnormalities in meningiomas with the embryological origins of the meninges.

Atsushi Okano1, Satoru Miyawaki2, Hiroki Hongo1, Shogo Dofuku1, Yu Teranishi1, Jun Mitsui3, Michihiro Tanaka4, Masahiro Shin1, Hirofumi Nakatomi1, Nobuhito Saito1.   

Abstract

Certain driver mutations and pathological diagnoses are associated with the anatomical site of meningioma, based on which the meninges have different embryological origins. We hypothesized that mutations and pathological diagnoses of meningiomas are associated with different embryological origins. We comprehensively evaluated associations among tumor location, pathological diagnosis (histological type), and genetic alterations including AKT1, KLF4, SMO, POLR2A, and NF2 mutations and 22q deletion in 269 meningioma cases. Based on the embryological origin of meninges, the tumor locations were as follows: neural crest, paraxial mesodermal, and dorsal mesodermal origins. Tumors originating from the dura of certain embryologic origin displayed a significantly different pathological diagnoses and genetic abnormality ratio. For instance, driver genetic mutations with AKT1, KLF4, SMO, and POLR2A, were significantly associated with the paraxial mesodermal origin (p = 1.7 × 10-10). However, meningiomas with NF2-associated mutations were significantly associated with neural crest origin (p = 3.9 × 10-12). On analysis of recurrence, no difference was observed in embryological origin. However, POLR2A mutation was a risk factor for the tumor recurrence (p = 1.7 × 10-2, Hazard Ratio 4.08, 95% Confidence Interval 1.28-13.0). Assessment of the embryological origin of the meninges may provide novel insights into the pathomechanism of meningiomas.

Entities:  

Year:  2021        PMID: 33772057      PMCID: PMC7998008          DOI: 10.1038/s41598-021-86298-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  39 in total

Review 1.  Histological classification and molecular genetics of meningiomas.

Authors:  Markus J Riemenschneider; Arie Perry; Guido Reifenberger
Journal:  Lancet Neurol       Date:  2006-12       Impact factor: 44.182

2.  NF2 status of meningiomas is associated with tumour localization and histology.

Authors:  J Kros; K de Greve; A van Tilborg; W Hop; H Pieterman; C Avezaat; R Lekanne Dit Deprez; E Zwarthoff
Journal:  J Pathol       Date:  2001-07       Impact factor: 7.996

Review 3.  Developmental biology of the meninges.

Authors:  Krishnakali Dasgupta; Juhee Jeong
Journal:  Genesis       Date:  2019-03-13       Impact factor: 2.487

Review 4.  Contribution of cranial neural crest cells to mouse skull development.

Authors:  Taofen Wu; Guiqian Chen; Fei Tian; Hong-Xiang Liu
Journal:  Int J Dev Biol       Date:  2017       Impact factor: 2.203

5.  Selective vulnerability of the primitive meningeal layer to prenatal Smo activation for skull base meningothelial meningioma formation.

Authors:  Julien Boetto; Caroline Apra; Franck Bielle; Matthieu Peyre; Michel Kalamarides
Journal:  Oncogene       Date:  2018-05-22       Impact factor: 9.867

6.  NF2 mutations in secretory and other rare variants of meningiomas.

Authors:  Christian Hartmann; Jennifer Sieberns; Claire Gehlhaar; Matthias Simon; Werner Paulus; Andreas von Deimling
Journal:  Brain Pathol       Date:  2006-01       Impact factor: 6.508

7.  Development and tissue origins of the mammalian cranial base.

Authors:  B McBratney-Owen; S Iseki; S D Bamforth; B R Olsen; G M Morriss-Kay
Journal:  Dev Biol       Date:  2008-07-22       Impact factor: 3.582

8.  Genomic Analysis of Posterior Fossa Meningioma Demonstrates Frequent AKT1 E17K Mutations in Foramen Magnum Meningiomas.

Authors:  Sally R Williams; Tareq A Juratli; Brandyn A Castro; Tyler T Lazaro; Corey M Gill; Naema Nayyar; Matthew R Strickland; Melanie Babinski; Sarah E Johnstone; Matthew P Frosch; Ian M Silverman; Heather A Ely; Alexander B Kaplan; Megan R D'Andrea; Ivanna V Bihun; Kaitlin Hoang; Emily Batchelor; Jason Christiansen; Daniel P Cahill; Frederick G Barker; Priscilla K Brastianos
Journal:  J Neurol Surg B Skull Base       Date:  2019-01-10

9.  TERT Promoter Mutations and Risk of Recurrence in Meningioma.

Authors:  Felix Sahm; Daniel Schrimpf; Adriana Olar; Christian Koelsche; David Reuss; Juliane Bissel; Annekathrin Kratz; David Capper; Sebastian Schefzyk; Thomas Hielscher; Qianghu Wang; Erik P Sulman; Sebastian Adeberg; Arend Koch; Ali Fuat Okuducu; Stefanie Brehmer; Jens Schittenhelm; Albert Becker; Benjamin Brokinkel; Melissa Schmidt; Theresa Ull; Konstantinos Gousias; Almuth Friederike Kessler; Katrin Lamszus; Jürgen Debus; Christian Mawrin; Yoo-Jin Kim; Matthias Simon; Ralf Ketter; Werner Paulus; Kenneth D Aldape; Christel Herold-Mende; Andreas von Deimling
Journal:  J Natl Cancer Inst       Date:  2015-12-13       Impact factor: 13.506

10.  PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss.

Authors:  Matthieu Peyre; Céline Salaud; Estelle Clermont-Taranchon; Michiko Niwa-Kawakita; Stephane Goutagny; Christian Mawrin; Marco Giovannini; Michel Kalamarides
Journal:  Oncotarget       Date:  2015-10-20
View more
  7 in total

1.  Clinicopathologic Characteristics of Grade 2/3 Meningiomas: A Perspective on the Role of Next-Generation Sequencing.

Authors:  Junhyung Kim; Kihwan Hwang; Hyun Jung Kwon; Ji Eun Lee; Kyu Sang Lee; Gheeyoung Choe; Jung Ho Han; Chae-Yong Kim
Journal:  Front Oncol       Date:  2022-06-13       Impact factor: 5.738

2.  NF2 Alteration/22q Loss Is Associated with Recurrence in WHO Grade 1 Sphenoid Wing Meningiomas.

Authors:  Yu Sakai; Satoru Miyawaki; Yu Teranishi; Atsushi Okano; Kenta Ohara; Hiroki Hongo; Daiichiro Ishigami; Daisuke Shimada; Jun Mitsui; Hirofumi Nakatomi; Nobuhito Saito
Journal:  Cancers (Basel)       Date:  2022-06-29       Impact factor: 6.575

Review 3.  Synthesizing Molecular and Immune Characteristics to Move Beyond WHO Grade in Meningiomas: A Focused Review.

Authors:  Nivedha V Kannapadi; Pavan P Shah; Dimitrios Mathios; Christopher M Jackson
Journal:  Front Oncol       Date:  2022-05-31       Impact factor: 5.738

4.  Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index.

Authors:  Yu Teranishi; Atsushi Okano; Satoru Miyawaki; Kenta Ohara; Daiichiro Ishigami; Hiroki Hongo; Shogo Dofuku; Hirokazu Takami; Jun Mitsui; Masako Ikemura; Daisuke Komura; Hiroto Katoh; Tetsuo Ushiku; Shumpei Ishikawa; Masahiro Shin; Hirofumi Nakatomi; Nobuhito Saito
Journal:  Acta Neuropathol Commun       Date:  2022-05-15       Impact factor: 7.578

5.  Telomere length was associated with grade and pathological features of meningioma.

Authors:  Keiko Yamakawa; Yuri Mukai; Juanjuan Ye; Mariko Muto-Ishizuka; Masumi Ito; Misa Tanimoto; Futoshi Suizu; Kenichiro Asano; Akira Kurose; Yoko Matsuda
Journal:  Sci Rep       Date:  2022-04-12       Impact factor: 4.379

6.  Transcriptomic Profiling Revealed Lnc-GOLGA6A-1 as a Novel Prognostic Biomarker of Meningioma Recurrence.

Authors:  Hanus Slavik; Vladimir Balik; Filip Zavadil Kokas; Rastislav Slavkovsky; Jana Vrbkova; Alona Rehulkova; Tereza Lausova; Jiri Ehrmann; Sona Gurska; Ivo Uberall; Marian Hajduch; Josef Srovnal
Journal:  Neurosurgery       Date:  2022-05-16       Impact factor: 5.315

7.  Posterior fossa ependymoma in neurodevelopmental syndrome caused by a de novo germline pathogenic POLR2A variant.

Authors:  Roberto Paparella; Anna Maria Caroleo; Emanuele Agolini; Giovanni Chillemi; Evelina Miele; Lucia Pedace; Martina Rinelli; Simone Pizzi; Luigi Boccuto; Giovanna Stefania Colafati; Mariachiara Lodi; Antonella Cacchione; Andrea Carai; Maria Cristina Digilio; Paolo Tomà; Marco Tartaglia; Angela Mastronuzzi
Journal:  Am J Med Genet A       Date:  2022-06-11       Impact factor: 2.578

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.